3-31533161-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate

The NM_178862.3(STT3B):ā€‹c.163C>Gā€‹(p.Pro55Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,303,536 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: š‘“ 0.00013 ( 0 hom., cov: 32)
Exomes š‘“: 0.000012 ( 0 hom. )

Consequence

STT3B
NM_178862.3 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.187
Variant links:
Genes affected
STT3B (HGNC:30611): (STT3 oligosaccharyltransferase complex catalytic subunit B) The protein encoded by this gene is a catalytic subunit of a protein complex that transfers oligosaccharides onto asparagine residues. Defects in this gene are a cause of congenital disorder of glycosylation Ix (CDG1X). [provided by RefSeq, Jun 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), STT3B. . Gene score misZ 3.7557 (greater than the threshold 3.09). Trascript score misZ 3.2395 (greater than threshold 3.09). GenCC has associacion of gene with STT3B-congenital disorder of glycosylation.
BP4
Computational evidence support a benign effect (MetaRNN=0.12570152).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
STT3BNM_178862.3 linkuse as main transcriptc.163C>G p.Pro55Ala missense_variant 1/16 ENST00000295770.4 NP_849193.1 Q8TCJ2
STT3BXM_011533465.2 linkuse as main transcriptc.163C>G p.Pro55Ala missense_variant 1/10 XP_011531767.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
STT3BENST00000295770.4 linkuse as main transcriptc.163C>G p.Pro55Ala missense_variant 1/161 NM_178862.3 ENSP00000295770.2 Q8TCJ2
STT3BENST00000453168.5 linkuse as main transcriptn.524C>G non_coding_transcript_exon_variant 1/101
STT3BENST00000423527.5 linkuse as main transcriptn.190C>G non_coding_transcript_exon_variant 1/102

Frequencies

GnomAD3 genomes
AF:
0.000132
AC:
20
AN:
151206
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000121
AC:
14
AN:
1152330
Hom.:
0
Cov.:
32
AF XY:
0.0000161
AC XY:
9
AN XY:
557436
show subpopulations
Gnomad4 AFR exome
AF:
0.000526
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
AF:
0.000132
AC:
20
AN:
151206
Hom.:
0
Cov.:
32
AF XY:
0.000136
AC XY:
10
AN XY:
73796
show subpopulations
Gnomad4 AFR
AF:
0.000484
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000147
ExAC
AF:
0.0000189
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 26, 2024The c.163C>G (p.P55A) alteration is located in exon 1 (coding exon 1) of the STT3B gene. This alteration results from a C to G substitution at nucleotide position 163, causing the proline (P) at amino acid position 55 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.077
T
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.29
FATHMM_MKL
Benign
0.60
D
LIST_S2
Benign
0.50
T
M_CAP
Pathogenic
0.74
D
MetaRNN
Benign
0.13
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
-0.31
N
REVEL
Benign
0.086
Sift
Benign
0.30
T
Sift4G
Benign
0.48
T
Polyphen
0.0
B
Vest4
0.22
MutPred
0.22
Loss of glycosylation at P51 (P = 0.0033);
MVP
0.13
MPC
0.82
ClinPred
0.12
T
GERP RS
3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.11
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs763113809; hg19: chr3-31574653; API